Multiple cerebral infarctions and dementia associated with anticardiolipin antibodies
B M Coull1, D N Bourdette, S H Goodnight
1Department of Neurology, Oregon Health Sciences University, Portland.
Insights
Anticardiolipin antibodies, linked to blood clots, were found in patients with unexplained strokes and dementia. Testing for these antibodies may help diagnose neurological issues in patients without lupus.
Area of Science:
- Neurology
- Immunology
- Cardiology
Background:
- Antibodies to negatively charged phospholipids, such as cardiolipin, are associated with systemic lupus erythematosus.
- These antibodies can indicate an increased risk of thrombotic events.
Observation:
- Four patients presented with cerebral infarctions and dementia.
- These patients tested positive for anticardiolipin antibodies.
- Crucially, these patients lacked lupus anticoagulant and a diagnosis of systemic lupus erythematosus.
Findings:
- The presence of anticardiolipin antibodies correlated with multiple cerebral infarctions in patients without systemic vasculitis or inflammatory conditions.
- This suggests a potential link between anticardiolipin antibodies and unexplained cerebrovascular events.
Implications:
- Testing for anticardiolipin antibodies may be beneficial for patients experiencing unexplained cerebral infarctions.
- This finding could lead to earlier diagnosis and intervention for a subset of patients with neurological deficits.
Abstract:
Antibodies to negatively charged phospholipids including cardiolipin have been recognized in the sera of patients with systemic lupus erythematosus and other disorders. We report 4 patients who experienced cerebral infarctions and dementia in association with anticardiolipin antibodies. These patients did not have the characteristic lupus anticoagulant or systemic lupus erythematosus. The occurrence of anticardiolipin antibodies in patients with multiple cerebral infarctions who do not have evidence of a systemic vasculitis or inflammatory condition suggests that this association may be more common than previously recognized. It may be useful to test for the presence of anticardiolipin antibodies in patients who have unexplained cerebral infarctions.
Related Concept Videos
Myocarditis I: Introduction
Ischemic Stroke l: Introduction
Transient Ischemic Attack l: Introduction
Encephalitis l: Introduction
Alzheimer Disease l: Introduction
Dementia l: Introduction


